These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 12534615)
1. Why do I have psoriasis? Cox NH; Paterson WD Br J Dermatol; 2003 Jan; 148(1):169. PubMed ID: 12534615 [No Abstract] [Full Text] [Related]
2. Measurement of involved surface area in patients with psoriasis. Ramsay B; Lawrence CM Br J Dermatol; 1991 Jun; 124(6):565-70. PubMed ID: 2064940 [TBL] [Abstract][Full Text] [Related]
4. [Clinical aspects of psoriasis]. Beylot C Rev Prat; 2004 Jan; 54(1):19-27. PubMed ID: 15049595 [No Abstract] [Full Text] [Related]
5. Global assessment of psoriasis severity and change from photographs: a valid and consistent method. Farhi D; Falissard B; Dupuy A J Invest Dermatol; 2008 Sep; 128(9):2198-203. PubMed ID: 18418412 [TBL] [Abstract][Full Text] [Related]
6. Tele-assessment of Psoriasis Area and Severity Index: a study of the accuracy of digital image capture. Singh P; Soyer HP; Wu J; Salmhofer W; Gilmore S Australas J Dermatol; 2011 Nov; 52(4):259-63. PubMed ID: 22070699 [TBL] [Abstract][Full Text] [Related]
7. The size of lesions, or point counting as a step toward the solution of the PASI problem. Bahmer F Arch Dermatol; 1989 Sep; 125(9):1282-3. PubMed ID: 2774606 [No Abstract] [Full Text] [Related]
8. Application of machine vision to assess involved surface in patients with psoriasis. Savolainen L; Kontinen J; Röning J; Oikarinen A Br J Dermatol; 1997 Sep; 137(3):395-400. PubMed ID: 9349336 [TBL] [Abstract][Full Text] [Related]
10. Computer-aided analysis with Image J for quantitatively assessing psoriatic lesion area. Sun Z; Wang Y; Ji S; Wang K; Zhao Y Skin Res Technol; 2015 Nov; 21(4):437-43. PubMed ID: 25661416 [TBL] [Abstract][Full Text] [Related]
11. Assessment of disease progress in psoriasis. Marks R; Barton SP; Shuttleworth D; Finlay AY Arch Dermatol; 1989 Feb; 125(2):235-40. PubMed ID: 2643928 [TBL] [Abstract][Full Text] [Related]
12. The objective evaluation of the severity of psoriatic scales with desquamation collecting tapes and image analysis. Kim JH; Kim BY; Choi JW; Kim SO; Lee HS; Park KC; Youn SW Skin Res Technol; 2012 May; 18(2):143-50. PubMed ID: 21507073 [TBL] [Abstract][Full Text] [Related]
13. Computerized quantification of psoriasis lesions with colour calibration: preliminary results. Iyatomi H; Oka H; Hagiwara M; Miyake A; Kimoto M; Ogawa K; Tanaka M Clin Exp Dermatol; 2009 Oct; 34(7):830-3. PubMed ID: 19438532 [TBL] [Abstract][Full Text] [Related]
14. Implications of psoriasis as a new disease. Altschuler EL Dermatology; 1999; 199(1):1-2. PubMed ID: 10449948 [TBL] [Abstract][Full Text] [Related]
15. [On water-soluble proteins in normal and psoriatic epidermis. I. The PAA-gel-electrophoretic protein spectrum]. Marghescu S Arch Klin Exp Dermatol; 1967; 228(3):327-32. PubMed ID: 4171695 [No Abstract] [Full Text] [Related]
16. Paradoxical, Cupping-Induced Localized Psoriasis: A Koebner Phenomenon. Vender R; Vender R J Cutan Med Surg; 2015; 19(3):320-2. PubMed ID: 25775648 [TBL] [Abstract][Full Text] [Related]
17. Why psoriasis looks that way. Kingery FA JAMA; 1966 Mar; 195(11):953. PubMed ID: 5951971 [No Abstract] [Full Text] [Related]
18. Efalizumab-associated papular psoriasis: an adverse reaction to efalizumab in three cases. Antonucci A; Bardazzi F; Balestri R; Patrizi A J Dermatolog Treat; 2009; 20(1):61-2. PubMed ID: 18618361 [TBL] [Abstract][Full Text] [Related]
19. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Leigh IM; Navsaria H; Purkis PE; McKay IA; Bowden PE; Riddle PN Br J Dermatol; 1995 Oct; 133(4):501-11. PubMed ID: 7577575 [TBL] [Abstract][Full Text] [Related]